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Abstract
Antimicrobial stewardship (AMS) aims to optimise treatment, minimise the risk of adverse effects and reduce health care costs. In
addition, it is recognised as a key component to stop the current spread of antimicrobial resistance in Europe. Educational
programmes are particularly important for the successful implementation of AMS. Training should start during medical school,
continue during clinical training and be reinforced throughout postgraduate training. National core curricula for paediatric
training should include passive and active training of competencies needed for AMS and future paediatricians should be skilled
in taking leadership roles in AMS initiatives. Other core members of the paediatric AMS team should also receive training
focused on the unique medical needs of the paediatric patient.
Conclusion: Ideally, all communities, hospitals and health regions in Europe should have AMS that serve all patient types,
including children. We all have the responsibility to ensure that existing antibiotics remain effective.
What is Known:
• Antimicrobial stewardship (AMS) is a key component to stop the current spread of antimicrobial resistance
• Educational programmes are particularly important for the successful implementation of AMS
What is New:
• All medical doctors in Europe who will be undertaking significant practice in child health should master the competencies needed to prescribe
antibiotics to children rationally as described in the European Academy of Paediatrics (EAP) Curriculum for Common Trunk Training in Paediatrics
• Interdisciplinary approaches of education need to be developed, as all hospitals and health regions in Europe ideally should have AMS programmes
that serve all patient types, including children
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Introduction
Antimicrobial resistance (AMR) poses a serious and increasing
threat to public health as infections caused by bacteria that are
resistant to antimicrobials lead to approximately 25,000 deaths
in the European Union every year [7]. In children, a significant
increase in the prevalence of multidrug-resistant bacterial infec-
tions has occurred during the past couple of decades [5]. Over
the last few years, there have been significant shortages in the
development and availability of new antibiotics, and the num-
ber of targeted studies on antibiotics in children remains strik-
ingly low [23]. Therefore, the implementation of strategies to
preserve the efficacy of existing antibiotics is an urgent public
health priority, both in hospital and community settings.
Antimicrobial stewardship (AMS) aims to appropriately and
safely prescribe antibiotics to patients, while reducing unneces-
sary or suboptimal use of antibiotics, thus maximising outcomes
for the patient [2]. AMS is recognised as a key component to stop
the current spread of AMR in Europe. AMS programmes have
the ultimate goal of minimising selective pressure on the emer-
gence of drug-resistant strains. Successful AMS programmes are
characterised by the ability to break down activities into specific
interventions that can be more easily implemented, monitored
and evaluated [3]. Successfully implemented AMS programmes
have a significant impact on reducing antimicrobial use in paedi-
atric patients, costs and prescribing errors without negative im-
pacts on patient safety, and actually resulting in improved patient
outcomes [13, 23, 24]. The identification of paediatric conditions
with both frequent and variable antimicrobial use could guide the
prioritisation of high-impact targets for AMS interventions [10].
Paediatric AMS should not be limited to the hospital setting and
collaboration among hospital and outpatient health care facilities
is of paramount importance [12, 14]. Indeed, AMS can be effec-
tive in reducing antibiotic misuse in community settings [9, 11,
26], and potential strategies to promote these programmes in
community-based settings have been published [14].
Training in antimicrobial stewardship
As active participation of clinical professionals at all levels of
care is required for AMS to succeed, educational programmes
are particularly important for the successful implementation of
AMS [25]. Education of health care providers on appropriate
antibiotic prescribing has been shown to enhance other anti-
microbial stewardship interventions [22]. Therefore, the
European Academy of Paediatrics (EAP) Curriculum for
Common Trunk Training in Paediatrics [6] includes specific
knowledge and skills related to AMR and the European
Society for Paediatric Infectious Diseases (ESPID) and other
national (paediatric) infectious diseases groups run specific
courses on AMR (Table 2). The syllabus for Core Training
sets out a European road map for common paediatric training.
It is intended as a guide for national paediatric societies to help
them understand the principles of core training. The EAP rec-
ognises that in many countries in Europe, training does not
conform to these recommendations, but as such differences
gradually diminish, quality, content and assessment of train-
ing, including training related to the principles AMR, will
become more uniform across Europe. At the same time, it is
recognised that differences in regional epidemiology and
healthcare infrastructure require a tailor-made approach, also
for AMS. Recently, recommendations were published for key
points to be included in clinical curricula, in order to develop
the necessary skills to participate in AMS [20, 22]. These are
summarised in Table 1. It is important that assimilation of
knowledge about AMS starts already during medical school,
is continued during clinical training and is reinforced through-
out postgraduate training. Passive educational techniques like
large and small group presentations are modestly effective for
increasing knowledge. However, interactive or dynamic tech-
niques influence prescribing behaviour. This includes educa-
tion associated with specific episodes of patient care.
Interactive small group sessions, e-learning, educational
outreach, periodic retrospective audit and feedback and
one-on-one patient-directed education have been shown
to be moderately to highly effective in optimising antibiotic
use and patient outcomes [22]. In particular, internet-based
education shows encouraging results [15, 17, 18]. The advan-
tages of e-learning include improved access to education in
rural or low-resource areas and the potential to develop an
interactive platform. Several examples of e-learning tools are
listed in Table 2. In addition, AMS was recently taught during
the EAP MasterCourse 2017 and is included in the upcoming
European Academy of Paediatric Societies congress in Paris,
2018. In addition, AMS is always covered during the annual
residential ESPID-Oxford Course.
Although many of the overarching principles of AMS ap-
ply to children and adults alike, many factors related to pae-
diatric AMS are unique to children. Children have high rates
of infection and frequently present with non-specific symp-
toms adding to diagnostic uncertainty. Patterns of infection
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Table 1 Key points to include in clinical AMS curricula [adapted from [20, 22]
Learning objective(s) Topics
Effect of AMS initiatives on
clinical outcome
The participant learns about how AMS contributes to
accurate and safer prescribing of antimicrobials,
resulting in improved clinical outcomes
Effective treatment
Clinical outcomes (mortality and morbidity)
Reduction of side effects
Population specific approaches
Effect of AMS initiatives on
bacterial resistance
The participant learns about antibiotic resistance
mechanisms, including causes and extent
Epidemiology (global)
Genetics and mechanisms
Relationship to antibiotic use
Discussion of AMS initiatives like prospective audit
with feedback and formulary restriction
The participant learns how AMS reduces the spread of
antimicrobial resistance
Diagnosis of infection The participant learns how to accurately interpret
laboratory reports in order to make clinical treatment
decisions in neonates, infants, children and adolescents;
Proper use and interpretation of bacterial Gram
stain/culture, rapid and point-of-care tests, serology,
and biomarkers of infection
Establishment of standardised diagnostic criteria for
specific infections
The participant learns how to diagnose an infection in a
standardised manner;
Principles of infection
management in children
The participant learns how to make informed treatment
decisions early in the course of disease in order to
positively influence treatment outcomes;
Promptly identify patients who require antibiotics
Timely and appropriate initiation of antibiotics
Obtain cultures before starting antibiotics
Do not give antibiotics with overlapping activity or
combinations not supported by evidence or
guidelines
The participant learns how to de-escalate antibiotic use in
order to more effectively treat an infection while limit-
ing exposure to broad-spectrum antimicrobials
Determine and verify antibiotic allergies
Consider local antibiotic susceptibility
Specify expected duration of therapy based on
evidence and national and hospital guidelines
Ensure appropriate administration (intravenous versus
oral)
Give antibiotics at the right dose and interval
Stop or de-escalate therapy promptly based on the cul-
ture and sensitivity results or establishment of an
alternative diagnosis
Reconcile and adjust antibiotics at all transitions and
changes in patient’s condition
Monitor for toxicity reliably and adjust agent and dose
promptly
Prescribing of antibiotics The participant learns the basics needed to prescribe
antibiotics for infections caused by susceptible and
resistant organisms
Pharmacokinetics and mechanism of action of different
classes of antibiotics (‘bug-drug’ coverage)
Pharmacology and adverse effects, including risk of
C. difficile infection
Principles of empirical versus directed therapy
Drug purchasing and dispensing costs
Guidelines for diagnosis and
management of most frequent
infections in children
Specific instruction for these common infections using
principles outlined above
Use of national and local guidelines and public health
guidance
Prevention of infection The participant learns about the importance of preventive
measures to limit the development of antimicrobial
resistance
Hand hygiene
Prudent use of catheters and devices
Principles and duration of surgical prophylaxis
Communication skills The participant learns how to apply communication
techniques to talk with patients and families about
prudent antibiotic use
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and resistance vary significantly by age, thus age-specific an-
tibiotic panels for antibiograms should preferably be used to
guide antibiotic choices for selected infections. Children are
more prone to infection with resistant organisms due to a
future lifetime of antibiotic exposure. In addition, consider-
ations related to age-appropriate dosing and formulations pose
challenges to the prescription of antibiotics in children [4].
Children may respond differently to antibiotics compared to
adults. Finally, immunisation initiatives should be included in
AMS programmes as a preventive strategy in both in- and
outpatient paediatric settings, in order to decrease the likeli-
hood of serious illness and to decrease AMR. Therefore, other
core members of the paediatric AMS team, like the microbi-
ologist, paediatric infectious disease specialist and clinical
pharmacist, should receive training focused on the unique
medical needs of the paediatric patient [16, 19]. In addition,
future paediatricians should be skilled in taking leadership
roles in AMS initiatives and develop practical solutions rooted
in the general principles of AMS, as it is important to further
expand AMS activities from the hospital to paediatric offices
and communities [14].
Keep antibiotics working
Limiting the further spread of AMR is one of EAP’s child
health priorities for 2017–2018. We will work together with
the European Centre for Disease Prevention and Control to
raise awareness about the relevance and benefits of cost-
effective AMS policies [21] and training in child health and
to advocate for sustained implementation of these across
Europe. Europe would greatly benefit from a uniform adop-
tion of AMR and infection prevention best practice across
countries. This includes harmonisation and simplification of
the various treatment guidelines that currently exist across
Europe. Moreover, there is an urgent need to conduct research
on new antibiotic (classes) for critical multi-drug-resistant
pathogens and on the effects of AMS programmes in low-
income countries in which emerging resistance are particular-
ly alarming [1]. In addition, limited access to high-quality
antibiotics is particularly of concern in these countries.
Continuous education and training of health care professionals
on appropriate antibiotic use is crucial. We therefore welcome
the new European Action Plan, which was launched this sum-
mer. The European Commission intends, among others, to
develop training programmes on AMR for health profes-
sionals through the ECDC and the EU health programme [8].
Conclusion
Prevention of AMR needs rigorous actions in the community,
at practice, ward, institutional, national and international
levels. Best practices should be applied cross-border and
healthcare institutions and communities should collaborate
regionally and internationally, in order to fight AMR success-
fully. Effective Europe-wide implementation and sustained
use of cost-effective antimicrobial policies can consequently
lead to improved safety and quality of care while contributing
to more sustainable healthcare. Ideally, all communities, hos-
pitals and health regions in Europe should have AMS
programmes that serve all patient types, including children.
This includes adult academic and community hospitals and
outpatient care centres that primarily care for children.
Therefore, the EAP is interested to discuss interdisciplinary
approaches of education with other stakeholders.
Prudent use of antibiotics is very important to address the
global challenges posed by AMR. We all have the responsi-
bility to ensure that existing antibiotics remain effective.
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Table 2 Available e-learning tools
AMS (general) Collection of AMS online courses made by the European Centre for Disease Prevention and Control:
https://ecdc.europa.eu/en/publications-data/directory-guidance-prevention-and-control/training-antimicrobial-stewardship
Massive Open Online Course on Antimicrobial Stewardship (University of Dundee, UK):
https://www.futurelearn.com/courses/antimicrobial-stewardship
Antimicrobial Stewardship Online CME Courses (Stanford University School of Medicine, USA):
https://med.stanford.edu/cme/learning-opportunities/antimicrobialstewardship.html
Paediatric AMS European Society for Paediatric Infectious Diseases (ESPID) online course on paediatric AMS:
http://www.espid.org/content.aspx?Page=ESPID%20Online%20Antibiotic%20Management%20Course
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